Shanghai Fudan-zhangjiang Bio-pharmaceutical Co., Ltd.
Clinical trials sponsored by Shanghai Fudan-zhangjiang Bio-pharmaceutical Co., Ltd., explained in plain language.
-
New hope for tough breast cancer: targeted drug faces chemo in Late-Stage trial
Disease control OngoingThis study tests a new drug called FDA018-ADC against standard chemotherapy in 350 people with advanced triple-negative breast cancer that came back after taxane treatment. The goal is to see if the new drug can delay cancer growth and improve survival. Participants are randomly …
Phase: PHASE3 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:08 UTC
-
New drug candidate targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-stage study tests an experimental drug called FDA018-ADC in about 78 adults with advanced solid tumors (like breast, lung, or bladder cancer) that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if i…
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC